BENAZEPRIL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Benazepril Hydrochloride, and when can generic versions of Benazepril Hydrochloride launch?
Benazepril Hydrochloride is a drug marketed by Amneal Pharms, Ani Pharms, Aurobindo Pharma, Chartwell Rx, Corepharma, Genpharm, Heritage Pharma, Prinston Inc, Rising, Sun Pharm Inds Ltd, Teva, Zydus Lifesciences, Apotex, Aurobindo Pharma Usa, Mylan Pharms Inc, and Sandoz. and is included in nineteen NDAs.
The generic ingredient in BENAZEPRIL HYDROCHLORIDE is benazepril hydrochloride; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the benazepril hydrochloride; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Benazepril Hydrochloride
A generic version of BENAZEPRIL HYDROCHLORIDE was approved as benazepril hydrochloride; hydrochlorothiazide by ANI PHARMS on February 11th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BENAZEPRIL HYDROCHLORIDE?
- What are the global sales for BENAZEPRIL HYDROCHLORIDE?
- What is Average Wholesale Price for BENAZEPRIL HYDROCHLORIDE?
Summary for BENAZEPRIL HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 19 |
| Finished Product Suppliers / Packagers: | 26 |
| Raw Ingredient (Bulk) Api Vendors: | 99 |
| Clinical Trials: | 44 |
| Patent Applications: | 1,963 |
| DailyMed Link: | BENAZEPRIL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for BENAZEPRIL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Lupus Research Alliance | Phase 2 |
| Northwell Health | Phase 2 |
| Shanghai Children's Hospital | Phase 2 |
Pharmacology for BENAZEPRIL HYDROCHLORIDE
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Decreased Blood Pressure |
Anatomical Therapeutic Chemical (ATC) Classes for BENAZEPRIL HYDROCHLORIDE
US Patents and Regulatory Information for BENAZEPRIL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | benazepril hydrochloride; hydrochlorothiazide | TABLET;ORAL | 077483-001 | Sep 8, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | BENAZEPRIL HYDROCHLORIDE | benazepril hydrochloride | TABLET;ORAL | 076211-002 | Feb 11, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | BENAZEPRIL HYDROCHLORIDE | benazepril hydrochloride | TABLET;ORAL | 076430-001 | Feb 11, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
